Fibrogen Inc (FGEN)

Nov 16, 2024

StockNews.com Begins Coverage on FibroGen (NASDAQ:FGEN) - Defense World

Nov 16, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Reduces Stake in FibroGen Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

FibroGen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024

Nov 13, 2024

FGEN stock touches 52-week low at $0.19 amid market challenges - Investing.com India

Nov 13, 2024

Nov 13, 2024

FibroGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Earnings call: FibroGen reports strong Q3 sales, advances in oncology pipeline - Investing.com UK

Nov 13, 2024

Nov 13, 2024

FibroGen: Q3 Earnings Snapshot - mySA

Nov 13, 2024

Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 13, 2024

Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions By GuruFocus - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

FibroGen Reports Strong Q3 Growth and Future Plans - TipRanks

Nov 12, 2024

Nov 12, 2024

FibroGen Inc earnings beat by $0.14, revenue topped estimates - Investing.com Australia

Nov 12, 2024

Nov 12, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings: Revenue Surges to $46.3M, EPS at $(0.17), Exceeding Estimates - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

FibroGen Q3 Revenue Surges 15% as China Sales Soar; Narrows Net Loss by 73% | FGEN Stock News - StockTitan

Nov 12, 2024

Nov 07, 2024

FibroGen Inc (FGEN) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register

Nov 07, 2024

Nov 04, 2024

FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewswire

Nov 04, 2024

Oct 31, 2024

Metrics That Matter About FibroGen Inc (NASDAQ: FGEN) - Stocks Register

Oct 31, 2024

Oct 29, 2024

FGEN stock touches 52-week low at $0.3 amid market challenges - Investing.com Australia

Oct 29, 2024

Oct 29, 2024

Little Excitement Around FibroGen, Inc.'s (NASDAQ:FGEN) Revenues As Shares Take 26% Pounding - Simply Wall St

Oct 29, 2024

Oct 29, 2024

FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

Oct 29, 2024

Oct 28, 2024

FGEN stock touches 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa

Oct 28, 2024

Oct 21, 2024

FibroGen (NASDAQ:FGEN) Research Coverage Started at StockNews.com - Defense World

Oct 21, 2024

Oct 16, 2024

The growth track for FibroGen Inc (FGEN) has changed recently - SETE News

Oct 16, 2024

Oct 15, 2024

Should investors be concerned about FibroGen Inc (FGEN)? - US Post News

Oct 15, 2024

Oct 15, 2024

Cubist Systematic Strategies LLC Has $256,000 Stock Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Oct 15, 2024

Oct 14, 2024

Market Watch: FibroGen Inc (FGEN)’s Noteworthy Gain, Closing at 0.36 - The Dwinnex

Oct 14, 2024

Oct 14, 2024

FibroGen Hits New 52-week High, What's Fuelling The Stock? - RTTNews

Oct 14, 2024

Oct 14, 2024

Pulmonary Fibrosis Drug Market Size & Analysis By 2024 -2034 -Boehringer Ingelheim, Roche, FibroGen, Inc., Merck & Co., – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024

Oct 12, 2024

Sei Investments Co. Purchases 41,442 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Oct 12, 2024

Oct 12, 2024

Financial Review: FibroGen (NASDAQ:FGEN) and Oncotelic Therapeutics (OTCMKTS:OTLC) - Defense World

Oct 12, 2024

Oct 11, 2024

FibroGen's US$6.2m Market Cap Fall Books Insider Losses - Simply Wall St

Oct 11, 2024

Oct 10, 2024

FibroGen Inc [FGEN] Chief Medical Officer makes an insider acquire of 22,123 shares worth 25,884. - Knox Daily

Oct 10, 2024

Oct 09, 2024

FibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts - Yahoo Finance

Oct 09, 2024

Oct 09, 2024

Investors in cash trouble should check out FibroGen Inc (FGEN) - SETE News

Oct 09, 2024

Oct 08, 2024

FGEN stock touches 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa

Oct 08, 2024

Oct 08, 2024

FGEN stock touches 52-week low at $0.33 amid market challenges - Investing.com Australia

Oct 08, 2024

Oct 08, 2024

A year in review: FibroGen Inc (FGEN)’s performance in the last year - US Post News

Oct 08, 2024

Oct 07, 2024

Trading Day Triumph: FibroGen Inc (FGEN) Ends at 0.37, a -8.07 Surge/Plunge - The Dwinnex

Oct 07, 2024

Oct 07, 2024

FibroGen Inc Inc. (FGEN) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 07, 2024

Oct 07, 2024

Investing in FibroGen Inc (FGEN): What You Must Know - Knox Daily

Oct 07, 2024

Oct 05, 2024

StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - Defense World

Oct 05, 2024

Oct 04, 2024

FibroGen will pay $10M to exit HQ lease in SF’s Mission Bay - The Real Deal

Oct 04, 2024

Oct 03, 2024

FibroGen Suit Alleging Disclosure Failures Tossed In Del. - Law360

Oct 03, 2024